Manuel Friese

Title: Manuel Friese: Innovator in Neurodegenerative Disease Treatment

Introduction

Manuel Friese is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of neurodegenerative disease treatment through his innovative research and development efforts. His work focuses on the inhibition of the TRPM4 ion channel, which plays a crucial role in various neurodegenerative conditions.

Latest Patents

Friese holds a patent for a method of treating or preventing neurodegeneration. This invention relates to a compound that effectively inhibits the function of the TRPM4 ion channel. The patent outlines the use of such a compound in treating or preventing neurodegenerative diseases, including Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis. Additionally, the invention provides a pharmaceutical composition comprising a TRPM4 inhibitory compound. It also includes in vitro methods for identifying pharmaceutically active compounds useful for treating or preventing neurodegenerative diseases. He has 1 patent to his name.

Career Highlights

Manuel Friese is associated with Reprise Pharmaceuticals, Inc., where he continues to advance his research in neurodegenerative diseases. His work has the potential to significantly impact the treatment landscape for patients suffering from these debilitating conditions.

Collaborations

Friese collaborates with notable colleagues, including Benjamin Schattling and Karin Steinbach, who contribute to his research endeavors.

Conclusion

Manuel Friese is a dedicated inventor whose work in neurodegenerative disease treatment showcases his commitment to improving patient outcomes. His innovative approaches and collaborations position him as a key figure in the field of medical research.